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ABSTRACT
Purpose: Investigate pain, fatigue, depressive symptoms and sleep disturbance in young adults with cere-
bral palsy compared to references.
Materials and methods: Young adults with cerebral palsy (n¼ 97, aged 21–34 years) and age-matched
references from the general population (n¼ 190) rated pain using a numeric rating scale and fatigue,
depressive symptoms, sleep disturbance and global health using Patient-Reported Outcomes
Measurement Information SystemVR short forms. Scores were compared between cerebral palsy subgroups
and the reference population. Correlation coefficients and linear regression analyses assessed interrela-
tionships of health issues and associations with global health.
Results: Individuals with Gross Motor Function Classification System level I had less pain, fatigue and
depressive symptoms, while individuals with levels II and III–V had more pain (53% and 56%, p< 0.001)
and those with levels III–V more fatigue (39%, p¼ 0.035) than references (pain: 26%, fatigue: 14%). Pain
and fatigue were more interrelated (correlation coefficients: 0.71 vs. 0.41) and stronger associated with
global mental health in individuals with cerebral palsy.
Conclusions: Young adults with Gross Motor Function Classification System levels II–V report more pain
and those with levels III–V report more fatigue than references. Pain and fatigue are highly interrelated
and specifically relate to mental health in individuals with cerebral palsy.
 IMPLICATIONS FOR REHABILITATION
 Except for those in the highest level of motor function, young adults with cerebral palsy report
higher levels of pain and fatigue compared to the general population of the same age.
 Pain and fatigue are strongly interrelated and associated with mental health in young adults with
cerebral palsy.
 The present study recommends to monitor pain and fatigue in young adults with cerebral palsy with
low levels of gross motor function.
 We advise rehabilitation professionals to consider combined treatment for both pain and fatigue.
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Introduction
Cerebral palsy (CP) is the most common childhood-onset
physical disability [1]. Much of the past research on CP focused
on children and physical problems, but in recent years attention
has broadened towards functioning and health of adults with
CP [2]. Pain and fatigue are reported in children with CP and
increase with age, as these children become adults [3–5].
Depressive symptoms and sleep disturbance are associated to
pain and fatigue in other populations, but this is not known for
adults with CP. Knowledge of health issues is especially relevant
in individuals in their twenties, since at that age they have to
develop adult roles, which includes managing their health and
healthcare [6]. Thus, in order to identify possible healthcare needs,
more insight should be attained in health issues in young adults
with CP.
Pain and fatigue are often studied, found to be highly preva-
lent and to occur more often in adults with CP than in the gen-
eral population [2,4,7–10]. The literature is inconclusive on
differences between subgroups of severity of motor impairment:
some found no differences in subgroups [5,9,11], while others
indicated that more severely impaired individuals have more pain
and fatigue [10,12,13]. Moreover, for specific subgroups of
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individuals with CP health issues were not compared to reference
values. Therefore, studying pain and fatigue in individuals with CP
in their twenties by level of gross motor functioning in compari-
son to a reference population could provide valuable new insight.
Depressive symptoms and sleep disturbance have been
studied less often in individuals with CP, but may be relevant
issues as well and are assumed to correlate with pain and fatigue
[9,14]. There is some evidence that adults with CP are at increased
risk of depressive symptoms compared to the general population
[15]. Also, depressive symptoms were more prevalent in a sample
of adults with CP [9]. In this sample, pain, depressive symptoms
and fatigue were described as a symptom cluster, similar to the
clustering that is observed in individuals with other chronic condi-
tions [9,16,17]. A recent study confirmed these associations in
adults with CP, and also found associations with sleep disorders
[18]. Furthermore, sleep disturbance is recognized as an underem-
phasized health issue in individuals with disabilities and occurs
frequently in children with CP [19,20], but has amply been studied
in adults with CP. Knowledge of depressive symptoms and sleep
disturbance may establish the relevance of these health issues in
treatment of young adults with CP.
Individuals’ overall health and wellbeing is reflected in their
perceived global health. Global health is known to be associated
with pain and fatigue in adults with CP [21–23], but the associ-
ation with depressive symptoms and sleep disturbance is
unknown. Moreover, it is unknown whether associations between
health issues and global health differ between individuals with CP
and the general population. Insight in these associations may
inform health professionals on the impact of health issues and
can help to prioritize treatment goals.
Thus, knowledge gaps exist regarding levels of depressive
symptoms and sleep disturbance in young adults with CP and the
clustering of these health issues with pain and fatigue. In add-
ition, levels of health issues and their impact on global health of
individuals with CP have not been studied for specific subgroups,
in comparison to the general population. We therefore aimed to
assess whether pain, fatigue, depressive symptoms and sleep dis-
turbance levels in young adults with CP differ between GMFCS
subgroups from those of the general population of the same age.
Second, we aimed to study how these health issues interrelate
and their association to global physical and mental health com-
pared to the general population.
Methods
Design
This is a cross-sectional study in young adults with CP.
Participants were former participants of the Pediatric
Rehabilitation Research in the Netherlands program that recruited
cohorts of children with CP between 2002 and 2007 in the
Netherlands for a prospective cohort study.
Participants
Participants of the previous 9–16 and 16–24 years cohort studies
[6,24] were invited to participate in the current cross-sectional
study (current age: 21–34 years). Exclusion criteria for the present
study were additional disorders affecting motor functioning or
having an intellectual disability, which was classified as having
attended special education for children with intellectual disability
[24]. Of all 211 participants of the previous 9–16 years and
16–24 years cohort studies, 176 participants were eligible and 167
were invited to participate (Figure 1). The study was approved by
the medical ethical committees of VU University Medical Center
and Erasmus MC University Medical Center.
In addition, reference values of two samples representative of
the Dutch population were available from an online panel (Desan
Research Solutions; ww.desan.nl), assessed for validation studies
of the Dutch-Flemish PROMIS instruments. These samples were
composed to be representative of the general population with a
maximum of 2.5% deviation from the distributions of gender, age,
education, ethnicity and region, based on data from Statistics
Netherlands in 2016 or 2013. From these samples, observations of
individuals aged 21–34 years were selected [25,26].
Outcome measures
Pain, fatigue, depressive symptoms, sleep disturbance and global
physical and mental health were assessed using self-report ques-
tionnaires in online surveys. CP characteristics were classified in a
face-to face interview by a trained physical or occupational ther-
apist in participants with CP [27].
Type of CP was classified as unilateral spastic CP, bilateral spas-
tic CP or non-spastic CP [28]. The level of functional ability was
classified using the Gross Motor Function Classification System
(GMFCS), Manual Ability Classification System (MACS) and
Communication Function Classification System (CFCS), ranging
from I (most able) to V (least able) [29–31]. Highest level of
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(n=176)
Not interested in
follow-up (n=9)
Figure 1. Flow chart of inclusion of study participants.
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education of individuals with CP was classified as primary, second-
ary or tertiary according to the international standard classifica-
tion of education [32].
Pain was assessed as the average pain severity over the past
week using an 11-point numeric rating scale ranging from 0 (no
pain) to 10 (worst pain imaginable), which is one of the items of
the Global Health Version 1.2 scale (Global07r) of the PROMISVR
(Patient-Reported Outcomes Measurement Information System)
[25]. Pain scores 1–3 were considered mild, scores 4–7 moderate
and scores 8–10 severe [33]. This item was found valid and reli-
able to assess pain intensity in adults with CP [34].
Fatigue, depressive symptoms and sleep disturbance were
assessed using the Dutch-Flemish translations of the PROMIS v1.0
short forms 8a in the CP sample [25,26,35–37]. These PROMIS short
forms consist of eight items that are 7-day recall statements, scored
on 5-point Likert scales. Physical and mental health were assessed
using the PROMIS Global Health Version 1.2 scale [38]. Psychometric
properties of PROMIS measures for Fatigue, Depression, Sleep
Disturbance and Global Health have been studied extensively and
show acceptable to excellent reliability and validity across several
United States (US) and Dutch (clinical) populations [36,37,39–43]. In
reference samples, the Fatigue (95 items) and Sleep Disturbance
item banks (27 items) and Global Health Version 1.2 scale (including
the pain item) were answered by one sample (n¼ 190, aged
21–34), while the Depression item bank (28 items) was answered by
another sample (n¼ 202, aged 21–34). Response pattern scoring
was used to transform the PROMIS short form (adults with CP) or
full item banks (reference populations) and global health scale
scores into a T-score [40,43]. A T-score of 50 (with a SD of 10) repre-
sents the average of a representative sample from the US general
population. Higher scores indicate more of the concept being meas-
ured (i.e., more fatigue, better physical health). In line with the
PROMIS guidelines, scores for fatigue, depressive symptoms and
sleep disturbance of 55–60 were considered mild issues, 60–70
moderate issues and >70 severe issues [44]. Global mental and
physical health scores were classified “poor” (<34 for physical, <28
for mental health) to “excellent” (>58 for physical, >57 for mental
health), based on US population estimates [44,45].
Statistical analysis
SPSS for Windows was used for analyses and a p-value <0.05 was
considered statistically significant (SPSS 22, IBM SPSS Statistics,
Armonk, NY, USA). The median and interquartile range of pain
severity, and means and standard deviations of fatigue, depressive
symptoms and sleep disturbance, physical health and mental
health were computed for the total CP sample, GMFCS subgroups
and reference samples. Additionally, frequencies of mild, moderate
and severe issues were calculated. To study differences between
subgroups, scores of individuals with CP (total sample and GMFCS
subgroups I, II and III–V) and reference groups were compared
using logistic regression for pain (dichotomized for scores 0–2 ver-
sus scores >3) and linear regression analyses for fatigue, depressive
symptoms and sleep disturbance (T-scores). Because the distribu-
tion of gender differed between the CP sample and reference sam-
ples, and health issues are known to be associated to gender
[7,10], gender was expected to be a confounder in these analyses.
We therefore corrected the analyses for gender.
To study clustering of health issues, associations were deter-
mined between pain, fatigue, depressive symptoms and sleep dis-
turbance for individuals with CP and references using Spearman
(for associations with pain) and Pearson correlation coefficients,
except for associations with depressive symptoms in references
because these were assessed in another sample. The 95% confi-
dence intervals (CIs) of the estimated correlation coefficients indi-
cated whether correlation coefficients were significantly different
between groups.
To study associations of pain, fatigue, depressive symptoms
and sleep disturbance with global physical and mental health, lin-
ear regression analyses were conducted separately for individuals
with CP and references (except for depressive symptoms in the
reference population). Then, analyses were performed on the
combined data of both groups, including a grouphealth issue
interaction for pain, fatigue, and sleep disturbance, to determine
whether associations differed between individuals with CP and
the general population.
Results
Participant characteristics are presented in Table 1; 97 young adults
with CP (no intellectual disability) completed the measurements
(58% response rate, mean age: 28.5 years [SD: 3.8 years], 59% male).
Individuals in the reference sample for pain, fatigue and sleep dis-
turbance (n¼ 190) had a mean age of 28.1 years (SD: 3.7 years) and
56 (30%) were male, for depressive symptoms (n¼ 202) they had a
mean age of 28.1 years (3.9 years) and 76 (38%) were male.
Figure 2(a) shows the occurrence of mild, moderate and severe
health issues in the GMFCS subgroups and references. Of those
with GMFCS levels II and III–V 53% and 56% reported pain, respect-
ively, and of those with GMFCS levels III–V 39% reported fatigue. In
the reference samples 26% reported pain and 15% reported
fatigue. No differences between individuals with CP and references
were found in pain occurrence (defined as NRS > 3), and fatigue
and sleep disturbance scores. Depressive symptoms were less
severe (lower scores) in individuals with CP (Tables 2 and 3).
Table 1. Characteristics of study participants.
Participants with CP
without intellectual
disability (n¼ 97)
Mean age (SD) 28.5 years (3.8 years)
Age range 21.6–34.3 years
Male/female, n (%) 59/38 (61/39)
Highest educational level, n (%)
Primary education 6 (6)
Secondary education 41 (42)
Tertiary education 50 (51)
CP type, n (%)
Unilateral spastic CP 39 (40)
Bilateral spastic CP 44 (45)
Non-spastic CP 14 (15)
GMFCS level, n (%)
I 49 (51)
II 30 (31)
III 5 (5)
IV 10 (10)
V 3 (3)
MACS level, n (%)
I 49 (51)
II 41 (42)
III 4 (4)
IV 3 (3)
V –
CFCS level, n (%)
I 78 (80)
II 17 (18)
III 2 (2)
IV –
V –
SD: standard deviation; CP: cerebral palsy; GMFCS: Gross Motor Function
Classification System; MACS: Manual Ability Classification System; CFCS:
Communication Function Classification System.
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However, when individuals with GMFCS levels I, II and levels III–V
were analyzed separately, those with GMFCS level I had less severe
pain, fatigue and depressive symptoms compared to references.
Those with GMFCS levels II and III–V had higher odds of pain (OR
[CI]: 3.84 [1.69–8.74] and 4.32 [1.55–12.02]) and those with GMFCS
levels III–V had somewhat more severe fatigue (beta [SE]: 4.61
[2.31]) compared to references (Table 3).
Figure 3 shows the correlation coefficients between the health
issues in individuals with CP and the reference group. There were
positive associations between all health issues in both the individ-
uals with CP and references (see Figure 3). Pain and fatigue
correlated more strongly in individuals with CP compared to refer-
ences (r ¼ .71 vs. r ¼ .41).
Table 4 describes the associations between pain, fatigue,
depression, sleep disturbance and physical and mental health for
individuals with CP and references. All health issues related nega-
tively to global physical and mental health in individuals with CP
and references with standardized betas ranging from –0.25 to
–0.84. In individuals with CP pain and fatigue had a stronger asso-
ciation with mental health, and a weaker association with physical
health compared to references, as indicated by significant interac-
tions (see Table 4).
Figure 2. Proportions of health issues (a) and physical and mental health (b) of references (n¼ 190 for pain, fatigue, sleep disturbances and global health, n¼ 202
for depressive symptoms), individuals with GMFCS level I (n¼ 49), GMFCS level II (n¼ 30) and GMFCS levels III–V (n¼ 18).
Table 2. Descriptives of perceived health outcomes of young adults with CP without intellectual disability and an age-matched reference population.
Health issues
CP (all) GMFCS level I GMFCS level II GMFCS levels III–V Reference population
Mean (SD); n¼ 97 Mean (SD); n¼ 49 Mean (SD); n¼ 30 Mean (SD); n¼ 18 Mean (SD); n¼ 190/202a
Painb, NRS-scale, range 0–10 2 (0–4.5) 0 (0–2) 4 (2–6) 5 (2–7) 1 (0–4)
Fatigue, PROMIS, T-score 48.6 (9.9) 44.3 (8.0) 52.2 (8.2) 54.3 (12.3) 50.5 (9.5)
Depression, PROMIS, T-score 46.7 (8.6) 43.9 (6.7) 49.5 (10.6) 49.4 (7.3) 51.5 (9.4)
Sleep disturbance, PROMIS, T-score 50.1 (7.8) 48.1 (8.0) 51.8 (8.0) 52.8 (5.8) 50.9 (8.3)
Global health Mean (SD); n¼ 97 Mean (SD); n¼ 49 Mean (SD); n¼ 30 Mean (SD); n¼ 18 Mean (SD); n ¼ 190
Physical health, PROMIS, T-score 49.0 (8.6) 51.6 (7.7) 46.4 (9.0) 46.0 (8.7) 48.7 (7.1)
Mental health, PROMIS, T-score 47.9 (9.9) 54.3 (7.3) 42.5 (7.3) 39.3 (8.1) 45.7 (7.9)
CP: cerebral palsy; SD: standard deviation; GMFCS: Gross Motor Function Classification System; NRS: Numeric Rating Scale; PROMIS: Patient-Reported Outcomes
Measurement Information System.
aReference population for depression, n¼ 202.
bMedian (interquartile range).
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Discussion
This study provided insight into the health issues in individuals
with CP in their twenties. Young adults with CP with GMFCS lev-
els II and III–V more often reported moderate to severe pain (53%
and 56%) and those with GMFCS levels III–V more often reported
moderate to severe fatigue (39%) than a reference group (pain:
26%, fatigue: 15%). In contrast, those with GMFCS level I had
lower levels of pain, fatigue and depressive symptoms. Pain and
fatigue showed a stronger inter-relationship in individuals with
CP, and correlated more strongly to mental health compared to a
reference group.
Pain in subgroups of GMFCS levels have not been previously
compared to reference populations. Our result of much higher
moderate to severe pain occurrence in individuals with GMFCS
levels II–V compared to GMFCS level I is in line with a recent
meta-analysis that found more pain in individuals with CP with
GMFCS levels II and IV compared to GMFCS level I [10]. Some
other studies did not identify this difference, which may be
explained by lower numbers of individuals with GMFCS level I in
these populations, and therefore they may not have had enough
power to determine the difference [9,11]. Furthermore, these pop-
ulations had a slightly higher age than the present sample which
may explain the different results. In conclusion, pain occurs often
in young adults with GMFCS levels II–V and we therefore advise
professionals to monitor pain in these individuals.
Regarding fatigue, we found somewhat higher severity levels
in individuals with CP with GMFCS levels III–V (mean T-score: 54.3)
compared to those in the reference population (mean T-score:
50.5). Previous studies did not compare subgroups of GMFCS to
reference values, but did find that individuals with lower motor
Table 3. Regression coefficients for the differences in pain, fatigue, depression and sleep disturbance between individuals with CP and references.
Dependent Pain Fatigue Depressive symptoms Sleep disturbance
Independent
Odds ratio; 95% CI;
p-value
Beta (SE); std beta;
p-value
Beta (SE); std beta;
p-value
Beta (SE); std beta;
p-value
Crude analysis CP (versus references) 1.25; 0.73 to
2.15; p¼ 0.410
–1.87 (1.20);
–0.09; p¼ 0.121
–4.78 (1.14);
–0.24; p< 0.001
–0.78 (1.02);
–0.05; p¼ 0.448
Adjusted for gender CP (versus references) 1.50; 0.85 to
2.67; p¼ 0.163
–1.03 (1.25);
–0.051; p¼ 0.412
–4.87 (1.11);
–0.24; p< 0.001
–0.35 (1.07);
–0.02; p¼ 0.742
Crude analysis GMFCS I
(versus references)
0.25; 0.09 to
0.73; p¼ 0.011
–6.17 (1.49);
–0.24; p< 0.001
–7.51 (1.45);
–0.30; p< 0.001
–2.78 (1.30);
–0.13; p¼ 0.033
GMFCS II
(versus references)
3.20; 1.46 to
7.03; p¼ 0.004
1.74 (1.83);
0.06; p¼ 0.343
–1.97 (1.78);
–0.06; p¼ 0.268
0.89 (1.59);
0.03; p¼ 0.578
GMFCS III–V
(versus references)
3.50; 1.31 to
9.37; p¼ 0.013
3.81 (2.30);
0.10; p¼ 0.098
–2.05 (2.23);
–0.05; p¼ 0.360
1.92 (2.00);
0.06; p¼ 0.331
Adjusted for gender GMFCS I
(versus references)
0.30; 0.10 to
0.89; p¼ 0.030
–5.32 (1.54);
–0.21; p¼ 0.001
–7.62 (1.48);
–0.30; p< 0.001
–2.35 (1.34);
–0.11; p¼ 0.081
GMFCS II
(versus references)
3.84;
1.69–8.74; p¼ 0.001
2.43 (1.85);
0.08; p¼ 0.190
–2.06 (1.79);
–0.07; p¼ 0.252
1.24 (1.62);
0.05; p¼ 0.445
GMFCS III–V
(versus references)
4.32; 1.55 to
12.02; p¼ 0.005
4.61 (2.31);
0.12; p¼ 0.047
–2.15 (2.25);
–0.06; p¼ 0.339
2.33 (2.03);
0.07; p¼ 0.252
CP: Cerebral Palsy; GMFCS: Gross Motor Function Classification System; SE: standard error; std beta: standardized beta.p 0.05; p 0.01.
Figure 3. Correlations among pain, fatigue, depressive symptoms and sleep disturbance of individuals with CP and references (in grey and italics).
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function experience more fatigue compared to those with higher
motor function [9,12]. Therefore, our results emphasize that
fatigue is an issue in individuals with GMFCS levels III–V in their
twenties. We therefore suggest to monitor fatigue in young adults
with CP during their transition from adolescence into adulthood.
Young adults with CP did not have higher levels of depressive
symptoms and sleep disturbance compared to an age-matched
reference group. This is in contrast with the literature that found
individuals with CP at higher risk of depression compared to refer-
ence values [9,14]. A possible explanation for this may be a floor
effect in the assessment of depressive symptoms. This floor effect
was observed in other studies as well [42], and is more pro-
nounced in the short form that was used for individuals with CP
than in the item bank that was used in the reference population
[46]. Because of this, the Depression short form does not seem to
adequately cover low scores on the depressive symptoms short
form [46], which may have led to an underestimation of the aver-
age level of depressive symptoms in individuals with CP. Still, this
only affects the scores of those with low levels of depressive
symptoms, the scores of individuals with moderate to severe
depressive symptoms were not affected. Therefore, since depres-
sive symptoms and sleep disturbance were not more severe in
individuals with CP compared to the general population in their
twenties they may not require specific attention in rehabilita-
tion care.
Remarkably, we did not find a difference in pain and fatigue
between the total sample and the reference population, contrast-
ing other studies [4,7–9]. This can be explained by the large pro-
portion of individuals with GMFCS level I in our sample, who had
very low levels of pain and fatigue. These low levels may be
related to the lifelong aspect of their disability. Similar to the
response shift theory, individuals with CP are accustomed to func-
tioning with their disability, may have struggled with health issues
in the past, and therefore rate their health more positively [47].
As expected, all health issues in individuals with CP and the
general population were associated, in line with the literature
[9,16–18]. Moreover, our results support the idea that there is a
clustering of pain and fatigue in individuals with CP [8,48], which
was also found in individuals with stroke [16]. Because of the low
occurrence of depressive symptoms we did not confirm a triad of
pain, fatigue and depressive symptoms that was previously found
in a population of individuals with bilateral CP and in individuals
after stroke [9,16]. Furthermore, the association between fatigue
and sleep disturbance tended to be less prominent in individuals
with CP compared to the general population. This may be caused
by a stronger correlation in individuals with CP between fatigue
and other health complaints, like pain or physical limitations, than
between fatigue and sleep. For the healthier reference group on
the other hand, sleep problems could be a major issue causing
fatigue. Although the underlying mechanism of the association
between pain and fatigue is unclear, health professionals may
consider treating pain and fatigue in combination if both issues
occur. A lifestyle intervention program may for instance be fitting,
since this has previously found to reduce both fatigue and
pain [49].
All health issues had a negative association with global health.
This is in line with previous studies that found associations
between pain and fatigue with global health in children with CP
and associations of pain and fatigue with health concerns of
adults with CP [21,23]. In addition, pain and fatigue were more
strongly associated to mental health, but weaker to physical
health in young adults with CP compared to the general popula-
tion. Pain and fatigue therefore seem to affect mood and quality
of life, which determine the PROMIS global mental health score.
Global physical health was less affected by pain and fatigue in
individuals with CP compared to the reference population in our
study. This may be explained by their physical disabilities that
may be dominant in rating their global physical health. In conclu-
sion, our results suggest that pain and fatigue should be inter-
vened on timely in young adults with CP to prevent reduced
mental health. In addition, in line with a recently developed
patient-centered research agenda for CP, future research may aim
to determine which variables, in addition to GMFCS level predict
the occurrence of pain and fatigue in young adulthood [50].
Strengths and limitations
Strengths of this study are studying four health issues and global
health simultaneously, thus allowing to disentangle associations
between them and directly comparing the results to a reference
population of the same age. Limitations mainly concern represen-
tativeness of the used samples. First, we checked that non-
response of participants from the previous representative CP
cohorts for this study was not selective regarding gender, GMFCS
level and type of CP, and the distribution of these factors was
similar to population-based studies in CP when excluding those
with intellectual disability [51]. Despite this, we cannot rule out
that other specific factors may have caused individuals to not
respond to this study. Second, the reference groups were repre-
sentative of the Dutch population within the age range
18–40 years [25]. Since we selected an age subgroup from this
sample, deviations from norm data distributions may exceed
2.5%. Deviations in distributions were observed for gender (refer-
ence samples had an overrepresentation of women). We therefore
Table 4. Regression coefficients for the relations between pain, fatigue, depression, sleep disturbance and physical and mental health for individuals with CP and
references.a
Dependent Physical health Mental health
beta (SE); std beta; p-value beta (SE); std beta; p-value
Independent CP References Interaction CP References Interaction
Pain –1.05 (0.31);
–0.33; p¼ 0.001
–1.98 (0.17);
–0.64; p< 0.001
0.93 (0.32);
0.24; p¼ 0.004
–3.04 (0.21);
–0.84; p< 0.001
–0.86 (0.24);
–0.25; p< 0.001
–2.18 (0.34);
–0.50; p< 0.001
Fatigue –0.34 (0.08);
–0.39; p< 0.001
–0.49 (0.04);
–0.65; p< 0.001
0.15 (0.08);
0.47; p¼ 0.067
–0.73 (0.07);
–0.73; p< 0.001
–0.44 (0.05);
–0.53; p< 0.001
–0.29 (0.09);
–0.78; p¼ 0.001
Depressive symptoms –0.63 (0.08);
–0.63; p< 0.001
–0.52 (0.11);
–0.45; p< 0.001
Sleep disturbance –0.44 (0.10);
–0.40; p< 0.001
–0.48 (0.05);
–0.57; p< 0.001
0.04 (0.10);
0.14; p¼ 0.676
–0.60 (0.12);
–0.47; p< 0.001
–0.42 (0.06);
–0.44; p< 0.001
–0.18 (0.12);
–0.51; p¼ 0.130
CP: cerebral palsy; SE: standard error; std beta: standardized beta.
aCorrecting analyses for gender provides very similar results and are therefore not presented.p 0.05; p 0.01.
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corrected our analyses for gender to allow conclusions on differ-
ences in health issues between individuals with CP and samples
from the general population. Third, the relatively small size of the
population of individuals with CP limited the study. We combined
subgroups of individuals with GMFCS levels III–V to have
adequate group sizes for the analyses, because of low numbers of
individuals with GMFCS levels III and V. Future studies are needed
to confirm our results in separate groups of individuals with
GMFCS levels III–V.
Conclusions
Young adults with CP and GMFCS levels II–V report higher levels
of pain and those with GMFCS levels III–V report higher levels of
fatigue compared to age-matched individuals from the general
population, while those with GMFCS level I report lower levels of
pain, fatigue and depressive symptoms. Pain and fatigue are
strongly interrelated and are specifically associated with mental
health in young adults with CP. Therefore, we recommend that
health professionals monitor pain and fatigue in young adults
with GMFCS levels II–V and consider combined treatment for
both health issues. Depressive symptoms and sleep disturbance
do not seem to be more prominent in young adults with CP com-
pared to the general population of the same age.
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